OBJECTIVE: The purpose of the study is to evaluate the efficacy and safety of proton therapy in complicated circumscribed @entity3193 . DESIGN: The study design was a retrospective review. @entity1 : Studied were 13 @entity1 (13 eyes) who had circumscribed @entity3193 associated with @entity1713 . Of these, four eyes previously underwent laser unsuccessfully. INTERVENTION: Proton therapy including a total dose of 30 Cobalt-Gray-Equivalent was administered to each eye. MAIN OUTCOME MEASURES: @entity1 were controlled for initial and final best-corrected visual acuity, slit-lamp examination, intraocular pressure, fundus examination, @entity941 angiography, and @entity5 thickness on B-scan ultrasonography. RESULTS: The mean follow-up period was 26 months (range, 9-48 months). Retinal reattachment was obtained in all cases after a mean period of 52 days. The @entity5 height decreased in all cases. Visual acuity improved to two lines or more in eight eyes (62%) and reached 20/200 or more in nine eyes (69%). No radiation complication was detected during follow-up. CONCLUSIONS: Proton radiation seems to be effective and safe in the management of @entity3193 associated with @entity1713 . It may be useful when photocoagulation can not be performed.

Efficacy of proton therapy in circumscribed @entity3193 associated with serious XXXX .

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'PARTICIPANTS'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor'] @entity1713 :: ('MESH:D012163', 'Disease') :: ['serous retinal detachment'] @entity3193 :: ('MESH:D015862', 'Disease') :: ['choroidal hemangioma', 'choroidal hemangiomas'] @entity941 :: ('MESH:D019793', 'Chemical') :: ['fluorescein']
@entity1713 :: (MESH:D012163,Disease) :: ['retinal detachment']
